| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BRAINRESREV.2007.08.002 |
| P698 | PubMed publication ID | 17915333 |
| P50 | author | Georg Reiser | Q110281963 |
| P2093 | author name string | Weibo Luo | |
| Yingfei Wang | |||
| P433 | issue | 2 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 331-345 | |
| P577 | publication date | 2007-08-29 | |
| P1433 | published in | Brain Research Reviews | Q15763574 |
| P1476 | title | Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection | |
| P478 | volume | 56 |
| Q60951164 | A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma |
| Q36933268 | Activation of protease-activated receptor 2-mediated signaling by mast cell tryptase modulates cytokine production in primary cultured astrocytes |
| Q39181656 | Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders |
| Q45904111 | Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis. |
| Q36464329 | Baicalin protects against thrombin induced cell injury in SH-SY5Y cells |
| Q33745087 | Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease |
| Q36380440 | Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis. |
| Q33898338 | Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy. |
| Q37790898 | Current Perspective on the Role of the Thrombin Receptor in Cerebral Vasospasm After Subarachnoid Hemorrhage |
| Q92927537 | Cyclic nucleotide signaling in sensory neuron hyperexcitability and chronic pain after nerve injury |
| Q48326580 | Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups |
| Q47709165 | Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin. |
| Q47142040 | Effect of short term diet restriction on gene expression in the bovine hypothalamus using next generation RNA sequencing technology |
| Q58782042 | Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2 |
| Q36359579 | Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury |
| Q21245326 | Genetical genomic determinants of alcohol consumption in rats and humans |
| Q58114607 | Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation |
| Q34299008 | Identification of protease inhibitors by a fast fluorimetric assay |
| Q28477022 | Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease |
| Q42789192 | Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2. |
| Q51785375 | Inhibition of M current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception. |
| Q89577470 | Inhibition of PAR-2 Attenuates Neuroinflammation and Improves Short-Term Neurocognitive Functions via ERK1/2 Signaling Following Asphyxia-Induced Cardiac Arrest in Rats |
| Q42082620 | Inhibition of Protease-Activated Receptor 1 Does not Affect Dendritic Homeostasis of Cultured Mouse Dentate Granule Cells |
| Q94518214 | Inhibition of mast cell tryptase attenuates neuroinflammation via PAR-2/p38/NFκB pathway following asphyxial cardiac arrest in rats |
| Q42359958 | Interference with Protease-activated Receptor 1 Alleviates Neuronal Cell Death Induced by Lipopolysaccharide-Stimulated Microglial Cells through the PI3K/Akt Pathway |
| Q37466077 | Is multiple sclerosis a mitochondrial disease? |
| Q28477457 | Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study |
| Q42493460 | Microglia Activation and Polarization After Intracerebral Hemorrhage in Mice: the Role of Protease-Activated Receptor-1. |
| Q39361791 | Modulation of PAR(1) signalling by benzimidazole compounds |
| Q33832964 | Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition |
| Q42696477 | Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases |
| Q59808647 | Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System |
| Q28511266 | Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol |
| Q34403337 | Neuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells |
| Q34774194 | Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease |
| Q24315843 | Nexin-1 inhibits the activity of human brain trypsin |
| Q47335504 | Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development |
| Q39676378 | PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells. |
| Q53590746 | PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. |
| Q43159978 | Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis |
| Q91761178 | Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation |
| Q37675807 | Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4) |
| Q52923632 | Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier. |
| Q36259819 | Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury |
| Q38820329 | Protease-activated receptor-1 expression in rat microglia after trimethyltin treatment. |
| Q38680840 | Protease-activated receptors and their biological role - focused on skin inflammation |
| Q35357984 | Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases |
| Q24336249 | Proteinase-activated receptors, nucleotide P2Y receptors, and μ-opioid receptor-1B are under the control of the type I transmembrane proteins p23 and p24A in post-Golgi trafficking |
| Q28647166 | Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection |
| Q48377404 | Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2. |
| Q42513639 | Regulation of neuronal plasticity and fear by a dynamic change in PAR1-G protein coupling in the amygdala |
| Q44375033 | Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist |
| Q35053403 | Salmon and human thrombin differentially regulate radicular pain, glial-induced inflammation and spinal neuronal excitability through protease-activated receptor-1 |
| Q28741929 | Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior |
| Q37972789 | Targeting proteinase-activated receptors: therapeutic potential and challenges. |
| Q47854993 | The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review |
| Q38170064 | The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage |
| Q87726254 | The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism |
| Q48850978 | The phosphorylation status of extracellular-regulated kinase 1/2 in astrocytes and neurons from rat hippocampus determines the thrombin-induced calcium release and ROS generation |
| Q38908560 | Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention? |
| Q46804891 | Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. |
| Q26827343 | Thrombin regulation of synaptic transmission and plasticity: implications for health and disease |
| Q39643248 | Thrombin: is it on a par with seizures and epilepsy? |
| Q39773426 | Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells. |
| Q36164146 | Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation |
| Q38087217 | Treating seizures and epilepsy with anticoagulants? |
| Q92309537 | Weisheng-Tang Ameliorates Acute Ischemic Brain Damage in Mice by Maintaining Blood-Brain Barrier Integrity |
Search more.